These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2206860)

  • 1. Acute respiratory failure after intrathecal methotrexate administration.
    Martins da Cunha AC; Bartsch CH; Gadner H
    Pediatr Hematol Oncol; 1990; 7(2):189-92. PubMed ID: 2206860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.
    Jabbour E; O'Brien S; Kantarjian H; Garcia-Manero G; Ferrajoli A; Ravandi F; Cabanillas M; Thomas DA
    Blood; 2007 Apr; 109(8):3214-8. PubMed ID: 17209054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convulsions and intracranial calcifications in a leukemic infant receiving only intrathecal methotrexate as central nervous system prophylaxis.
    Russo A; Di Bella D; Lo Bianco M; Rizzari C; Schilirò G
    Pediatr Hematol Oncol; 1987; 4(3):269-72. PubMed ID: 3152931
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report.
    Laver JH; Barredo JC; Amylon M; Schwenn M; Kurtzberg J; Camitta BM; Pullen J; Link MP; Borowitz M; Ravindranath Y; Murphy SB; Shuster J
    Leukemia; 2000 Mar; 14(3):369-73. PubMed ID: 10720128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient encephalopathy following a single exposure of high-dose methotrexate in a child with acute lymphoblastic leukemia.
    Kubo M; Azuma E; Arai S; Komada Y; Ito M; Sakurai M
    Pediatr Hematol Oncol; 1992; 9(2):157-65. PubMed ID: 1381940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Lauer SJ; Camitta BM; Leventhal BG; Mahoney DH; Shuster JJ; Adair S; Casper JT; Civin CI; Graham M; Kiefer G
    Cancer; 1993 May; 71(9):2854-61. PubMed ID: 8467463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
    J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
    Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
    J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute respiratory distress syndrome following intrathecal methotrexate administration: a case report and review of literature.
    Dai MS; Ho CL; Chen YC; Kao WY; Chao TY
    Ann Hematol; 2000 Dec; 79(12):696-9. PubMed ID: 11195008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study.
    Bowman WP; Shuster JJ; Cook B; Griffin T; Behm F; Pullen J; Link M; Head D; Carroll A; Berard C; Murphy S
    J Clin Oncol; 1996 Apr; 14(4):1252-61. PubMed ID: 8648381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.
    Chamberlain MC; Glantz MJ
    Blood; 2007 Sep; 110(5):1698; author reply 1698-9. PubMed ID: 17712051
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia.
    von der Weid NX; de Crousaz H; Beck D; Deonna T; Miklossy J; Janzer RC
    Med Pediatr Oncol; 1991; 19(3):192-8. PubMed ID: 2023567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial Hemorrhage Following Intrathecal Methotrexate Therapy for Acute Lymphoblastic Leukaemia.
    Purkait R; Dolai TK; Lath C; Das B
    Indian Pediatr; 2016 May; 53(5):423-4. PubMed ID: 27254055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A Pediatric Oncology Group Pilot Study.
    Lauer SJ; Camitta BM; Leventhal BG; Mahoney D; Shuster JJ; Kiefer G; Pullen J; Steuber CP; Carroll AJ; Kamen B
    J Pediatr Hematol Oncol; 1998; 20(3):229-33. PubMed ID: 9628434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study.
    Sancho JM; Morgades M; Arranz R; Fernández-Abellán P; Deben G; Alonso N; Blanes M; Rodríguez MJ; Nicolás C; Sánchez E; Fernández de Sevilla A; Conde E; Ribera JM;
    Med Clin (Barc); 2008 Oct; 131(11):401-5. PubMed ID: 18928719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective prevention of central nervous system leukemia with intrathecal methotrexate and intrathecal methotrexate, cytosine arabinoside, and hydrocortisone in childhood acute lymphocytic leukemia.
    Aur RJ; Hanna M; Sabbah R; Sackey K; Willoughby S; Atwood J
    Haematol Blood Transfus; 1990; 33():504-10. PubMed ID: 2323651
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management.
    Rausch CR; Jabbour EJ; Kantarjian HM; Kadia TM
    Cancer; 2020 Mar; 126(6):1152-1160. PubMed ID: 31794095
    [No Abstract]   [Full Text] [Related]  

  • 20. [Spinal subacute combined degeneration after intrathecal chemotherapy. Report of two cases].
    Cartier R L; Parra V J; Puga B; Cardemil D
    Rev Med Chil; 2018 Jun; 146(6):802-807. PubMed ID: 30148913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.